The antibody-based pharmaceuticals resource library’s Podcast

Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.

https://www.creative-biolabs.com/

Eine durchschnittliche Folge dieses Podcasts dauert 11m. Bisher sind 318 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 2 days 18 hours 44 minutes

subscribe
share






episode 11: Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 December 22, 2022  17m
 
 

episode 12: Immunohistochemistry for Tumor-Infiltrating Immune Cells After Oncolytic Virotherapy


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 October 19, 2022  9m
 
 

episode 13: Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 October 19, 2022  11m
 
 

episode 14: Evaluation of Oncolytic Virus-Induced Therapeutic Tumor Vaccination Effects in Murine Tumor Models


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 October 19, 2022  10m
 
 

episode 15: Delivery of Oncolytic Reovirus by Cell Carriers


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 October 19, 2022  16m
 
 

episode 16: In Vivo Bioimaging for Monitoring Intratumoral Virus Activity


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 October 19, 2022  9m
 
 

episode 17: Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 October 19, 2022  14m
 
 

episode 18: Use of Liquid Patient Ascites Fluids as a Preclinical Model for Oncolytic Virus Activity


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 October 19, 2022  10m
 
 

episode 19: Generating Primary Models of Human Cancer to Aid in the Development of Clinically Relevant Oncolytic Viruses


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 October 19, 2022  9m
 
 

episode 20: Considerations for Clinical Translation of MG1 Maraba Virus-Ⅰ


Creative Biolabs has archived professional academic reports and the latest scientific progress of oncolytic virotherapy, by making it into a podcast column.


share








 October 19, 2022  11m